Generic drugmaker Nephron Pharmaceuticals raises $75 million in debt financing
Nephron Pharmaceuticals, a maker of generic respiratory meds, has raised $75 million in debt financing, according to a regulatory filing. The company is based in Orlando, Florida and employs about 500. It announced two years ago that it would expand its operations, building out an expansive South Carolina site with a $313 million investment. The company’s […]